Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

The newspaper Saturday reported while initial annual sales estimates for Viagra alone were around $5 billion, the total sales of the top three erectile medications have totaled $3 billion a year.

While sales of the drugs have been somewhat disappointing, they have been credited by some with making erectile dysfunction a less embarrassing medical condition.

"Before Viagra, a lot of men with erection problems were angry and withdrawn in their relationships," sex counselor Dr. Judy Kuriansky said. "They didn't want sex; their partners didn't know what was going on; the women blamed themselves, and it was a mess."

The Herald said that failure of the drug to work for all men may be behind the medication's lack of success as erections only occur in two out of three men when the problem has an organic basis.

Copyright 2007 by United Press International

Explore further: Medical charity accuses US of pushing India to ease patent rules

add to favorites email to friend print save as pdf

Related Stories

What goes up must come down

5 hours ago

Found in warm regions of the world, geckos are extremely capable of climbing up steep, smooth surfaces. To do so, they employ an adhesive system – a key evolutionary innovation that facilitates climbing ...

Hydraulic fracturing linked to earthquakes in Ohio

7 hours ago

Hydraulic fracturing triggered a series of small earthquakes in 2013 on a previously unmapped fault in Harrison County, Ohio, according to a study published in the journal Seismological Research Letters.

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments : 0